69 results
6-K
EX-99.2
SNY
Sanofi
28 Jul 23
Condensed Half-year Consolidated Financial Statements
7:00am
pipeline, refer to Section G/ of this half-year management report.
A.3. OTHER SIGNIFICANT EVENTS
A.3.1 CORPORATE GOVERNANCE
The Combined General
6-K
EX-99.1
SNY
Sanofi
2 Jun 23
Approval of the financial statements for the fiscal year 2022
10:53am
the highest standards of corporate governance.”
Following the General Meeting, the Board of Directors remains comprised of 16 members, of whom six
6-K
EX-99.2
SNY
Sanofi
28 Jul 22
Condensed Half-year Consolidated Financial Statements
6:17am
.
For an update on our research and development pipeline, refer to Section G/ of this half-year management report.
A.3. OTHER SIGNIFICANT EVENTS
A.3.1 CORPORATE … GOVERNANCE
The Combined General Shareholders’ Meeting of Sanofi was held on May 3, 2022 at Paris Expo Porte de Versailles, under the chairmanship
6-K
EX-99.1
SNY
Sanofi
4 Apr 22
Distribution of Shares of Euroapi
11:21am
of the Board of Directors
Declaration of compliance with the corporate governance system in force
Internal control
EMPLOYEES
Employment information
Stock … with the AFEP-MEDEF Code (see Section 15.4 “Declaration of compliance with the corporate governance system in force” of the Prospectus). In this regard
SC TO-T
EX-99
ky89ujlpthy1t5q45
16 Aug 21
Third party tender offer statement
8:09am
6-K
EX-99.2
uyv4g3w
2 Aug 21
Online availability of Sanofi’s half-year financial report for 2021
5:03pm
6-K
EX-99.1
2fc9lgwz
30 Jul 21
Current report (foreign)
4:01pm
6-K
EX-99.2
vh9db0qmy22h697rga
29 Jul 21
Current report (foreign)
10:48am
6-K
EX-99.2
7ts8s
4 Nov 20
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
3:27pm
6-K
EX-99.2
n2ninw
29 Jul 20
2020 Half-year Financial Report
10:13am
SC TO-T
EX-99
vk3a1qpk 2x5
27 Dec 19
Third party tender offer statement
5:27pm
6-K
EX-99.2
10ccel25
29 Jul 19
Half-year Financial Report
10:41am